RARA CRAFT DATABASE for FDA Medical Devices
510(k)K191826

FDA DEVICE FACTS

KeYi Total Hip System

Beijing Keyi Medical Device Technology Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 14, 2020PRODUCT CODELPH

Indications for use

The KeYi Total Hip System is designed for total hip arthroplasty. The indications for use are:

a. Significantly impaired joints resulting from rheumatoid, osteo, and post-traumatic arthritis.

b. Revision of failed femoral head replacement, cup arthroplasty or other hip procedures.

c. Proximal femoral fractures.

d. Avascular necrosis of the femoral head.

e. Non-union of proximal femoral neck fractures.

f. Other indications such as congenital dysplasia, arthrodesis conversion, coxa magna, coxa plana, coxa vara, coxa valga, developmental conditions, metabolic and tumorous conditions, osteomalacia, osteoporosis, pseudarthrosis conversion, and structural abnormalities. The KeYi femoral stems are indicated for cementless use. The KeYi acetabular shells are indicated for cemented or cementless use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026